- Report
- May 2024
- 200 Pages
Global
From €3730EUR$4,150USD£3,271GBP
- Report
- February 2024
- 120 Pages
Global
From €4269EUR$4,750USD£3,744GBP
- Report
- April 2023
- 75 Pages
Europe
From €4269EUR$4,750USD£3,744GBP
- Report
- October 2023
- 90 Pages
India
From €3146EUR$3,500USD£2,759GBP
- Report
- August 2024
- 82 Pages
Japan
From €3146EUR$3,500USD£2,759GBP
- Report
- August 2024
- 130 Pages
North America
From €3595EUR$4,000USD£3,153GBP
- Webinar
- April 2021
- 6 Hours
Global
From €535EUR$595USD£469GBP
The Adaptive Trial market is a subset of the Clinical Trials industry that focuses on the use of adaptive designs to improve the efficiency and effectiveness of clinical trials. Adaptive designs are a type of clinical trial design that allows for changes to be made to the trial protocol during the course of the trial, based on data collected from the trial. This allows for the trial to be tailored to the specific needs of the trial, and can help to reduce the time and cost of the trial.
Adaptive Trial designs are becoming increasingly popular in the Clinical Trials industry, as they can help to reduce the time and cost of trials, while still providing reliable results.
Some companies in the Adaptive Trial market include Cytel, Parexel, ICON, and Quintiles. Show Less Read more
